ESMO Lifetime Achievement Award

The Dutch Cancer Institute (NKI) has won the ESMO Lifetime Achievement Award, presented by The European Society for Medical Oncology, for its `excellent translational research into breast cancer´.

Photo: ESMO Lifetime Achievement Award

The NKI has bridged the field of molecular biological research and the clinic. In particular it has developed genetic assays for breast cancer that, according to ESMO, lead to better understanding of the disease and probably to more precise and less aggressive treatment.
The ESMO award – which includes ?50,000 for research - was presented for the second time; last year it went to the Breast International Group (BIG), a platform for clinical research into breast cancer.

Apologies instead of condolences
The wife of a patient, who had been treated in the ICU of the Medisch Spectrum Twente Hospital after receiving serious burns during a barbecue accident, received a questionnaire asking her to tell the hospital management about her experience with condolences she had received. The hospital letter arrived just as her husband arrived home. Its opening sentence read: ‘Recently your husband died in the intensive care ward….’ The hospital offered its apologies … better than condolences!

31.08.2007

More on the subject:

Related articles

Photo

News • Insights into asymptomatic disease cases

Some brains stay sharp in spite of Alzheimer’s – here's why

Why do some older adults remain mentally sharp despite having Alzheimer's? Decoding this natural resilience could pave the way for earlier detection and new strategies to prevent memory loss.

Photo

News • Targeted analysis

New technique maps cancer drug uptake inside living cells

A new analytical method could improve how cancer treatments are designed – by allowing scientists to track, for the first time, exactly where inside a living cell a drug accumulates.

Photo

News • Quicker diagnosis approach

New biosensor for detecting active tuberculosis

A research team is leading the development of a sensor that paves the way for the rapid, selective and cost-effective detection of active tuberculosis infection.

Subscribe to Newsletter